|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.IN |
First Approval Date01 Jan 2010 |
评价比索洛尔-氨氯地平5mg/5mg固定剂量复方片剂与两种片剂同时给药的随机,两阶段交叉的生物等效性研究。
[Translation] A randomized, two-period crossover bioequivalence study evaluating the efficacy of a bisoprolol-amlodipine 5 mg/5 mg fixed-dose combination tablet versus simultaneous administration of both tablets.
评估在空腹和进食状态下比索洛尔-氨氯地平固定剂量复方片剂(研究药物)单次口服给药与比索洛尔和氨氯地平片剂(对照药物)同时单次口服给药的生物等效性。
[Translation] To evaluate the bioequivalence of a single oral administration of a bisoprolol-amlodipine fixed-dose combination tablet (study drug) to a single oral administration of bisoprolol and amlodipine tablets (control drugs) in the fasted and fed states.
/ CompletedNot Applicable Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Hungary
This is a Hungarian, Multicentre, Observational Study to study Adherence and Long Term Outcomes of Therapy in paediatric subjects using easypod™ electromechanical device for growth hormone treatment to assess the level of adherence of subject receiving SAIZEN® via easypod™.
/ CompletedNot Applicable An Observational Program to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation (COS) in Assisted Reproductive Techniques (ART)
Human gonadotrophins have been successfully used for the treatment of infertility for more than 30 years. This observational study is being conducted to evaluate the efficacy and safety of the gonadotropins used for controlled ovarian stimulation (COS) in assisted reproductive technologies (ART).
100 Clinical Results associated with Merck Kft
0 Patents (Medical) associated with Merck Kft
100 Deals associated with Merck Kft
100 Translational Medicine associated with Merck Kft